Clinical Trials in Atlanta

Showing 8481-8500 of 19,805 trials

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

NCT00667459

The purpose of this clinical trial is to evaluate the safety and effectiveness of the PRESTIGE® LP Cervical Disc as a method of treating patients with symptoms of cervical degenerative disc disease at a single level from C3-C4 to C6-C7.

Cervical Degenerative Disc Disease

Medtronic Spinal and Biologics280 participantsStarted Jan 2005

Atlanta, Georgia, United States • Columbus, Georgia, United States • Coeur d'Alene, Idaho, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

NCT03657160

The purpose of this study is to evaluate the efficacy of vedolizumab when added to background aGvHD prophylaxis regimen compared to placebo and background aGvHD prophylaxis regimen on intestinal aGvHD-free survival by Day +180 in participants who receive allo-HSCT as treatment for a hematologic malignancy or myeloproliferative disorder.

Hematopoietic Stem Cells

Millennium Pharmaceuticals, Inc.343 participantsStarted Feb 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +136 more locations

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

Find Trials by Condition in Atlanta

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study of Diroximel Fumarate in the Real-World Setting

International Hernia Mesh Registry

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer